BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is common world-wide and associated with obesity, diabetes mellitus, cardiovascular disease, hyperuricaemia and dyslipidaemia. These conditions are common in New Zealand, but the prevalence of NAFLD in New Zealand is unknown. New Zealand has a high prevalence of overweight and obesity, so it is likely that NAFLD is also...

Diabetes Mellitus is estimated to affect around one million Australians, a number that is likely to increase in the future because of population ageing and increasing prevalence of risk factors such as obesity. This report mainly focuses on direct health care expenditure for diabetes - that is, money spent by governments, private health insurers, companies...

This paper describes the structure of the Cost Benefit Model of Diabetes Prevention and Care and lists the data sources used and assumptions embedded in the model. Agnes Walker, Stephen Colagiuri and Michele McLennan validate the model through checks of model outputs against data published by other organisations. They also discuss the sensitivity of model...